Archives

by in
Entry Author Date Location
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
As Its Investors Reap Returns, venBio Aims for a Bigger Second Fund 06/10/14 San Francisco
West Coast Biotech Roundup: Volcano, Twist, Calibr, ARMO, and More 05/29/14 San Francisco
Prostate Cancer Screening: Seduction Of The Innocent 05/28/14 Seattle
OncoGenex Retrenches, and Searches for Answers, After Failed Trial 05/22/14 Seattle
OncoGenex’s Long Wait For Cancer Drug Ends With a Phase 3 Stumble 04/28/14 Seattle
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
GenSpera’s Targeted “Death Carrot” Toxin in Trials for Two Cancers 03/27/14 Texas
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Drug Development 101: A Story About OncoGenex and the FDA 02/26/14 Seattle
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Madison Vaccines Closes $8M Series A Round for Prostate Treatment 01/13/14 Wisconsin
Houston’s MD Anderson Partners With Pfizer on Cancer Immunotherapies 01/08/14 Texas
Texas Roundup: Bellicum, Spredfast, People Pattern, Neos, Localeur 01/07/14 Texas
Report: Dendreon Looking to Get Acquired 10/26/13 Seattle
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Dendreon Says Sales Will Decline in 2013, Shares Fall 08/08/13 Seattle
Texas Roundup: Appconomy, Bellicum, and Datafiniti 07/12/13 Texas
San Diego Life Sciences Roundup: Aragon, Santarus, Tocagen, and More 06/20/13 San Diego
Isis Execs Upbeat as AstraZeneca Expands Cancer Drug Collaboration 06/05/13 San Diego
Genomic Health Test Aims To Cut Overtreatment of Prostate Cancer 05/08/13 San Francisco
Why Are Healthcare Costs Exploding? See Proton Cancer Therapy 03/18/13 National
Prostate Cancer Drug Winners and Losers at ASCO GU 02/15/13 National
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
Dendreon Shareholders Vent at Annual Meeting 06/13/12 Seattle
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
Page 1 of 7 next page »